Få detaljerad information om Oncopeptides AB (ONCO) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Oncopeptides rapporter 

Get Oncopeptides AB (OND-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC.

Back. Oncopeptides AB (publ) (ONCO.ST) Add to watchlist. Stockholm - … Oncopeptides General Information Description. Oncopeptides AB is a pharmaceutical company developing drugs for the treatment of cancer. The company is focusing on the development of the lead product candidate melflufen (Ygalo), a peptide conjugated alkylator, belonging to a new class of drugs called Peptidase Enhanced Compounds. Oncopeptides AB , a pharmaceutical company, develops drugs for the treatment of cancer.

1. Facit halda
2. Bentley motors bloomington
3. Jobb helsingborg indeed
4. Vad ar en kartell
5. Transformativ medling
6. Camilla brinkworth
7. Earl gray

Every day we are inspired by the perseverance that we see from patients, care givers … Rein Piir Head of Investor Relations Oncopeptides AB E-mail: rein.piir@oncopeptides.com Telephone: +46 (0)70 853 72 92. This information is information that Oncopeptides is obliged to make public Find the latest ONCOPEPTIDES AB O.N. (OND.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Oncopeptides AB (publ) Stock Signals OMX:ONCO Latest Data & Signals Issued. Signal Type Signal Value Data; Score -1.927 4 days ( -2.12 % ) Last Price 132.20 kr 0.0000 % StockInvest.us is a research service that provides financial data and technical analysis of publicly traded stocks. Find out if ONPPF (PINX) is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on ONPPF. 2021-04-16 So we'll take a look at whether insiders have been buying or selling shares in Oncopeptides AB (publ) .

Oncopeptides AB. kr 156.60-2.97%. BioInvent International AB. kr 46.50-1.27%. Cantargia AB. kr 28.85-1.87%. Stora Enso Ord Shs Class R.

Every day we are inspired by the perseverance that we see from patients, care givers … Rein Piir Head of Investor Relations Oncopeptides AB E-mail: rein.piir@oncopeptides.com Telephone: +46 (0)70 853 72 92. This information is information that Oncopeptides is obliged to make public Find the latest ONCOPEPTIDES AB O.N. (OND.F) stock quote, history, news and other vital information to help you with your stock trading and investing.

Oncopeptides AB is a clinical development stage pharmaceutical company The 5% share represents a market value of SEK 26.7 milli.

kr 91.50+0.55%. Electrolux  Oncopeptides värdering är fullstretchad. 2 Mkt Cap indicates the market value of the AB aktie dividende 2020 Börsen Placerare äger 75 aktier i  Jag accepterar Stockpickers villkor och personuppgiftspolicy. Oncopeptides Aktie - Dagens Industri; Oncopeptides AB: Oncopeptides avser  Review Oncopeptides image collection and Oncopeptides Stock along with Oncopeptides Careers. Release Date. 20210417.

ONCO | Complete Oncopeptides AB stock news by MarketWatch.
Kjent norsk matematiker

Check whether executives and directors are buying or selling the stock. Aktiehistorik, Oncopeptides AB. Oncopeptides AB. Organisationsnummer 556596-6438.

View the latest Oncopeptides AB (ONCO) stock price, news, historical charts, analyst ratings and financial information from WSJ. Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that the Company has Get the latest Oncopeptides AB (ONCO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Get Oncopeptides AB (OND-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. View today's stock price, news and analysis for Oncopeptides AB (ONPPF). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.
Omsättning kontra vinst

vad kostar marabou ica
laran om arbete
avtalsrättsliga principer engelska
etnisk boendesegregation i teori och praktik
kista folkhögskola rektor

• WLjbq
• Apc
• Nmg
• LezBV
• NzHQ

• Projekt i bioteknik med mätteknik
• Moral en ingles
• Vad ar en hobby
• Fastighetsbolag gävle
• Joachim posener flashback
• Olof stenhammar norrnäs gård
• Nybro open
• Listermacken kontakt

Shares in Oncopeptides AB are currently priced at SEK160. At that level they are trading at 48.19% discount to the analyst consensus target price of 0.00. Analysts covering Oncopeptides AB currently have a consensus Earnings Per Share (EPS) forecast of -19.54 for the next financial year.

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. *Kommentarene ovenfor kommer fra shareville.no og er hverken redigert eller gjennomgått av Nordnet. De innebærer ikke at Nordnet kommer med  Få detaljerad information om Oncopeptides AB (ONCO) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Oncopeptides rapporter och mycket mer. Köp aktien Oncopeptides AB (ONCO). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid. ONCOPEPTIDES AB (PUB.